Alerid
Alfacip
Amlopres
Ampisyn
Beclate
Budecort
Carloc
Cefasyn
Cefoprox
Cephadex
Ciplactin
Citadep
Clopivas
Cobix
Cromal
Cytomid
Cytotam
Danogen
Diaglip
Dilvas
Doxacard
Duolin
Duovir
Emeset
Etosid
Famtrex
Fertomid
Fincar
Flohale
Flomist
Forcan
Ginette
Glumet
Hipres
Ibugesic
Ipravent
Lomac
Mebex
Metolar
Misoprost
Modafinil
Montair
Norflox
Novamox
Osteofos
Oxyspas
Pantosec
Paracip
Pirox
Pletoz
Ralista
Ramipres
Serobid
Seroflo
Stavir
Terol
Tibofem
Tiova
Tramacip
Ulcimax
Venlor
Warf
Zidovir
Zoflut
|
Buy Duovir now!
Duovir.
Duovir = Lamivudine 150mg and Zidovudine USP 300mg
Duovir is used for treatment of an infection of a HIV, as a part of a combination therapy.
Recommended oral dosage Duovir for adults and teenagers (at least
12 years of age) - one tablet (containing 150 mg lamivudine and 300
mg zidovudine) twice daily with or without the foodstuffs.
Regulation of the dosage: as it - the established combination of a dosage, Duovir should
not, to be ordered for the patients demanding regulation of a dosage such as those
with the reduced kidney function (carrying out of calculations creatinine <50 ml / minutes), those with
low weight of a body (<50 kg or 110 pounds), or what test restriction of a dosage
adverse events.
| Warnings and Precautions. |
Duovir tablets are served by contra-indication in patients with preliminary shown
clinically essential hypersensitivity to any of components of a product.
Duovir-N = Lamivudine 150mg, Zidovudine USP 300mg, Nevirapine 200mg
Duovir-N is used for treatment of an infection of a HIV as soon as patients have
steady on a mode of service nevirapine a switching board on 200 mg, and
showed adequate tolerability to nevirapine.
Adults
1 tablet twice daily
Duovir-N should not cope to patients who have just started
therapy with nevirapine. It-, because initial leadership - in a somnolence of 200 mg
nevirapine once daily within 2 weeks it is recommended. After that leaderships - in
the dosage, rise of a dosage (dosage of service) to 200 mg nevirapine a switching board can
be it is executed in absence of any reactions of hypersensitivity (for example a rash,
function of a liver checks deviations.
The control of patients
Clinical tests of chemistry which include tests of function of a liver, should be
executed before introduction of leadership - in nevirapine therapies and in corresponding
intervals during therapy.
Regulation of the Dosage
As it - a combination of an establish - dosage, Duovir-N should not be ordered
for the patients demanding regulation of a dosage, such as those with a low body
weight (<50 kg), the reduced kidney function (carrying out of calculations creatinine <50 ml / minutes)
or what test adverse events limiting a dosage.
Duovir-N should be stopped, if patients test a serious rash or a
the rash accompanied with the constitutional results. The patients testing moderate to
decrease a rash during 14-day's leadership - during 200mg / days should not
do not increase them nevirapine a dosage or therapy of the beginning with Duovir-N up to
the rash has decided.
Duovir-N administration should be interrupted in overcoming patients
decrease or serious function of a liver checks deviations (excluding GGT),
while eminences of test of function of a liver have not come back to the basis. Nevirapine
(using Nevimune Tablets) can then to be repeatedly started in 200mg day.
The increase in a daily dosage to 200 mg twice daily (using Duovir-N) should be
made with caution, after the expanded supervision. Nevirapine should be
constantly stopped if the moderate or serious liver functions test
deviations come back.
Patients who interrupt nevirapine, dozing during more than 7 days, should begin repeatedly
recommended somnolence, use of one of 200 mg Nevimune a tablet daily for
first 14 days (leadership - â) in a combination with another antiretrovirals, accompanied
on 200mg twice daily using Duovir-N in absence of any signatures
hypersensitivity.
Harmed kidney and function of hepatic
any data are not accessible to recommend a dosage nevirapine in patients
with dysfunction hepatic, kidney lack or testing dialysis.
| Warnings and Precautions. |
Duovir-N is served by contra-indication in patients with clinically essential
hypersensitivity to any of the components containing in the formulation.
Duovir-N also is served by contra-indication for patients who only begin therapy
with nevirapine. These patients demand leadership - in a dosage nevirapine 200 mg o.d. whereas this formulation contains a dosage of service
nevirapine 200mg b.d.
|
|